319 related articles for article (PubMed ID: 17483335)
41. Nm23-H1 suppresses tumor cell motility by down-regulating the lysophosphatidic acid receptor EDG2.
Horak CE; Lee JH; Elkahloun AG; Boissan M; Dumont S; Maga TK; Arnaud-Dabernat S; Palmieri D; Stetler-Stevenson WG; Lacombe ML; Meltzer PS; Steeg PS
Cancer Res; 2007 Aug; 67(15):7238-46. PubMed ID: 17671192
[TBL] [Abstract][Full Text] [Related]
42. Autocrine motility factor signals integrin-mediated metastatic melanoma cell adhesion and invasion.
Timar J; Trikha M; Szekeres K; Bazaz R; Tovari J; Silletti S; Raz A; Honn KV
Cancer Res; 1996 Apr; 56(8):1902-8. PubMed ID: 8620512
[TBL] [Abstract][Full Text] [Related]
43. Crystal structures of mouse autocrine motility factor in complex with carbohydrate phosphate inhibitors provide insight into structure-activity relationship of the inhibitors.
Tanaka N; Haga A; Naba N; Shiraiwa K; Kusakabe Y; Hashimoto K; Funasaka T; Nagase H; Raz A; Nakamura KT
J Mol Biol; 2006 Feb; 356(2):312-24. PubMed ID: 16375918
[TBL] [Abstract][Full Text] [Related]
44. Loss of p63 leads to increased cell migration and up-regulation of genes involved in invasion and metastasis.
Barbieri CE; Tang LJ; Brown KA; Pietenpol JA
Cancer Res; 2006 Aug; 66(15):7589-97. PubMed ID: 16885358
[TBL] [Abstract][Full Text] [Related]
45. A role for perlecan in the suppression of growth and invasion in fibrosarcoma cells.
Mathiak M; Yenisey C; Grant DS; Sharma B; Iozzo RV
Cancer Res; 1997 Jun; 57(11):2130-6. PubMed ID: 9187109
[TBL] [Abstract][Full Text] [Related]
46. Down-regulation of EDAG expression by retrovirus-mediated small interfering RNA inhibits the growth and IL-8 production of leukemia cells.
Ling B; Zhou Y; Feng D; Shen G; Gao T; Shi Y; Wei H; Tian Z
Oncol Rep; 2007 Sep; 18(3):659-64. PubMed ID: 17671716
[TBL] [Abstract][Full Text] [Related]
47. Down-regulation of myopodin expression reduces invasion and motility of PC-3 prostate cancer cells.
De Ganck A; De Corte V; Bruyneel E; Bracke M; Vandekerckhove J; Gettemans J
Int J Oncol; 2009 May; 34(5):1403-9. PubMed ID: 19360353
[TBL] [Abstract][Full Text] [Related]
48. Novel roles of the autocrine motility factor/phosphoglucose isomerase in tumor malignancy.
Yanagawa T; Funasaka T; Tsutsumi S; Watanabe H; Raz A
Endocr Relat Cancer; 2004 Dec; 11(4):749-59. PubMed ID: 15613449
[TBL] [Abstract][Full Text] [Related]
49. Regulation of cell proliferation by autocrine motility factor/phosphoglucose isomerase signaling.
Tsutsumi S; Yanagawa T; Shimura T; Fukumori T; Hogan V; Kuwano H; Raz A
J Biol Chem; 2003 Aug; 278(34):32165-72. PubMed ID: 12783864
[TBL] [Abstract][Full Text] [Related]
50. Tumor invasion in the absence of epithelial-mesenchymal transition: podoplanin-mediated remodeling of the actin cytoskeleton.
Wicki A; Lehembre F; Wick N; Hantusch B; Kerjaschki D; Christofori G
Cancer Cell; 2006 Apr; 9(4):261-72. PubMed ID: 16616332
[TBL] [Abstract][Full Text] [Related]
51. Production of a motility factor by a newly established lung adenocarcinoma cell line.
Klominek J; Robért KH; Bergh J; Hjerpe A; Gahrton G; Sundqvist KG
Anticancer Res; 1998; 18(2A):759-67. PubMed ID: 9615717
[TBL] [Abstract][Full Text] [Related]
52. Inhibition of motility and invasiveness of renal cell carcinoma induced by short interfering RNA transfection of beta 1,4GalNAc transferase.
Aoki H; Satoh M; Mitsuzuka K; Ito A; Saito S; Funato T; Endoh M; Takahashi T; Arai Y
FEBS Lett; 2004 Jun; 567(2-3):203-8. PubMed ID: 15178323
[TBL] [Abstract][Full Text] [Related]
53. Fundamental study of small interfering RNAs for ganglioside GD3 synthase gene as a therapeutic target of lung cancers.
Ko K; Furukawa K; Takahashi T; Urano T; Sanai Y; Nagino M; Nimura Y; Furukawa K
Oncogene; 2006 Nov; 25(52):6924-35. PubMed ID: 16862187
[TBL] [Abstract][Full Text] [Related]
54. Epithelial-mesenchymal transition in ovarian cancer progression: a crucial role for the endothelin axis.
Bagnato A; Rosanò L
Cells Tissues Organs; 2007; 185(1-3):85-94. PubMed ID: 17587812
[TBL] [Abstract][Full Text] [Related]
55. Epithelial-to-mesenchymal transition and resistance to ingenol 3-angelate, a novel protein kinase C modulator, in colon cancer cells.
Ghoul A; Serova M; Astorgues-Xerri L; Bieche I; Bousquet G; Varna M; Vidaud M; Phillips E; Weill S; Benhadji KA; Lokiec F; Cvitkovic E; Faivre S; Raymond E
Cancer Res; 2009 May; 69(10):4260-9. PubMed ID: 19417139
[TBL] [Abstract][Full Text] [Related]
56. Expression of the serum response factor in hepatocellular carcinoma: implications for epithelial-mesenchymal transition.
Park MY; Kim KR; Park HS; Park BH; Choi HN; Jang KY; Chung MJ; Kang MJ; Lee DG; Moon WS
Int J Oncol; 2007 Dec; 31(6):1309-15. PubMed ID: 17982656
[TBL] [Abstract][Full Text] [Related]
57. Constitutive expression of RbAp46 induces epithelial-mesenchymal transition in mammary epithelial cells.
Li GC; Wang ZY
Anticancer Res; 2006; 26(5A):3555-60. PubMed ID: 17094482
[TBL] [Abstract][Full Text] [Related]
58. Insulin-like growth factor binding protein-3 interacts with autocrine motility factor/phosphoglucose isomerase (AMF/PGI) and inhibits the AMF/PGI function.
Mishra S; Raz A; Murphy LJ
Cancer Res; 2004 Apr; 64(7):2516-22. PubMed ID: 15059907
[TBL] [Abstract][Full Text] [Related]
59. Silencing of DUOX NADPH oxidases by promoter hypermethylation in lung cancer.
Luxen S; Belinsky SA; Knaus UG
Cancer Res; 2008 Feb; 68(4):1037-45. PubMed ID: 18281478
[TBL] [Abstract][Full Text] [Related]
60. HOXB2, an adverse prognostic indicator for stage I lung adenocarcinomas, promotes invasion by transcriptional regulation of metastasis-related genes in HOP-62 non-small cell lung cancer cells.
Inamura K; Togashi Y; Ninomiya H; Shimoji T; Noda T; Ishikawa Y
Anticancer Res; 2008; 28(4B):2121-7. PubMed ID: 18751384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
